70 related articles for article (PubMed ID: 21084104)
1. Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein.
Calvert AE; Kalantarov GF; Chang GJ; Trakht I; Blair CD; Roehrig JT
Virology; 2011 Feb; 410(1):30-7. PubMed ID: 21084104
[TBL] [Abstract][Full Text] [Related]
2. [Immunochemical properties of West Nile virus protein prM and protein M C-end].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Shvalov AN; Loktev VB
Mol Biol (Mosk); 2007; 41(1):8-17. PubMed ID: 17380886
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
Li L; Barrett AD; Beasley DW
Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
[TBL] [Abstract][Full Text] [Related]
4. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
[TBL] [Abstract][Full Text] [Related]
5. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.
Throsby M; Geuijen C; Goudsmit J; Bakker AQ; Korimbocus J; Kramer RA; Clijsters-van der Horst M; de Jong M; Jongeneelen M; Thijsse S; Smit R; Visser TJ; Bijl N; Marissen WE; Loeb M; Kelvin DJ; Preiser W; ter Meulen J; de Kruif J
J Virol; 2006 Jul; 80(14):6982-92. PubMed ID: 16809304
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
Purtha WE; Myers N; Mitaksov V; Sitati E; Connolly J; Fremont DH; Hansen TH; Diamond MS
Eur J Immunol; 2007 Jul; 37(7):1845-54. PubMed ID: 17559174
[TBL] [Abstract][Full Text] [Related]
8. [Immunochemical properties of short recombinant polypeptides of proteine of, the West Nile virus bearing epitopes of domains I and II].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Loktev VB
Mol Biol (Mosk); 2005; 39(5):813-22. PubMed ID: 16240715
[TBL] [Abstract][Full Text] [Related]
9. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
10. Expression of recombinant West Nile virus prM protein fused to an affinity tag for use as a diagnostic antigen.
Setoh YX; Hobson-Peters J; Prow NA; Young PR; Hall RA
J Virol Methods; 2011 Jul; 175(1):20-7. PubMed ID: 21545809
[TBL] [Abstract][Full Text] [Related]
11. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
12. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
13. Strain analysis and epitope mapping of West Nile virus using monoclonal antibodies.
Damle RG; Yeolekar LR; Rao BL
Acta Virol; 1998 Dec; 42(6):389-95. PubMed ID: 10358745
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a monoclonal antibody against prM protein of West Nile virus.
Guo LP; Huo H; Wang XL; Bu ZG; Hua RH
Monoclon Antib Immunodiagn Immunother; 2014 Dec; 33(6):438-43. PubMed ID: 25514166
[TBL] [Abstract][Full Text] [Related]
16. The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization.
Choi KS; Nah JJ; Ko YJ; Kim YJ; Joo YS
Virus Res; 2007 Feb; 123(2):216-8. PubMed ID: 17027114
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
18. The reactions of monoclonal antibodies with structural proteins of mumps virus.
Orvell C
J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
[TBL] [Abstract][Full Text] [Related]
19. Antiviral peptides targeting the west nile virus envelope protein.
Bai F; Town T; Pradhan D; Cox J; Ashish ; Ledizet M; Anderson JF; Flavell RA; Krueger JK; Koski RA; Fikrig E
J Virol; 2007 Feb; 81(4):2047-55. PubMed ID: 17151121
[TBL] [Abstract][Full Text] [Related]
20. West Nile virus envelope protein: role in diagnosis and immunity.
Wang T; Anderson JF; Magnarelli LA; Bushmich S; Wong S; Koski RA; Fikrig E
Ann N Y Acad Sci; 2001 Dec; 951():325-7. PubMed ID: 11797789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
